Senomyx

Beleggen in aandelen beurs New York, Dow Jones index, Nasdaq-100 en S&P500
Plaats reactie
Gebruikersavatar
Pantanirulez
Forum gebruiker
Forum gebruiker
Berichten: 147
Lid geworden op: 17 Aug 2015 15:32
waarderingen: 55
Contact:

Re: Senomyx

Berichtdoor Pantanirulez » 28 Apr 2017 20:03

Iemand enig nieuws hier, gaat lekker omhoog, maar heb geen reden gelezen.


Gebruikersavatar
johan1213
Forum gebruiker
Forum gebruiker
Berichten: 203
Lid geworden op: 31 Aug 2015 15:40
waarderingen: 64
Contact:

Re: Senomyx

Berichtdoor johan1213 » 28 Apr 2017 21:29

Pantanirulez liked last!

Gebruikersavatar
Pantanirulez
Forum gebruiker
Forum gebruiker
Berichten: 147
Lid geworden op: 17 Aug 2015 15:32
waarderingen: 55
Contact:

Re: Senomyx

Berichtdoor Pantanirulez » 01 Mei 2017 21:48

En nu terug in vrije val, wicked.

Gebruikersavatar
johan1213
Forum gebruiker
Forum gebruiker
Berichten: 203
Lid geworden op: 31 Aug 2015 15:40
waarderingen: 64
Contact:

Re: Senomyx

Berichtdoor johan1213 » 01 Mei 2017 22:59

Ja is geen aandeel voor lang in portefeuille te hebben tenzij je van risico's houdt.

Ik heb wel al een paar keer een goede trade gedaan, kopen rond die 0,90 en verkopen terug net onder 1 $. Schommelt al een tijdje rond die 0,90 cent. Dieptepunt voorlopig 0,86 cent dacht ik. Maar ik heb den indruk dat het op keer wel eens kan gedaan zijn met schommelen en dan definitief naar beneden kan gaan.
Pantanirulez liked last!

bien
Forum gebruiker
Forum gebruiker
Berichten: 223
Lid geworden op: 29 Apr 2013 17:38
waarderingen: 42
Contact:

Re: Senomyx

Berichtdoor bien » 02 Mei 2017 20:25

ja verleden vrijdag goedkeuring nieuwe zoetstof . nu nog winst maken en het kan omhoog !!! de vraag is waneer
Pantanirulez liked last!

Gebruikersavatar
Pantanirulez
Forum gebruiker
Forum gebruiker
Berichten: 147
Lid geworden op: 17 Aug 2015 15:32
waarderingen: 55
Contact:

Re: Senomyx

Berichtdoor Pantanirulez » 24 Mei 2017 14:15

Bron:https://sportsperspectives.com

Senomyx Inc. (SNMX) Given a $2.00 Price Target at Roth Capital
Posted by Brent Sawyer on May 23rd, 2017 // No Comments
Senomyx logoSenomyx Inc. (NASDAQ:SNMX) has been assigned a $2.00 price target by Roth Capital in a report issued on Tuesday, May 2nd. The firm currently has a “hold” rating on the specialty chemicals company’s stock. Roth Capital’s price objective would suggest a potential upside of 133.21% from the company’s previous close.
Separately, Zacks Investment Research downgraded shares of Senomyx from a “hold” rating to a “sell” rating in a research note on Saturday, April 29th.
Get Senomyx Inc. alerts:
Enter Your Email Address
Submit
Senomyx (NASDAQ:SNMX) opened at 0.8576 on Tuesday. The firm’s 50-day moving average price is $0.91 and its 200 day moving average price is $1.03. The company’s market capitalization is $40.75 million. Senomyx has a one year low of $0.78 and a one year high of $4.85.
Senomyx (NASDAQ:SNMX) last released its quarterly earnings data on Friday, April 28th. The specialty chemicals company reported ($0.07) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.01. Senomyx had a negative net margin of 39.68% and a negative return on equity of 54.22%. The firm had revenue of $4.47 million for the quarter, compared to the consensus estimate of $4.22 million. During the same period last year, the firm earned ($0.05) earnings per share. The company’s quarterly revenue was down 28.5% on a year-over-year basis. On average, equities research analysts expect that Senomyx will post ($0.27) earnings per share for the current fiscal year.
In other news, CEO John Poyhonen bought 50,000 shares of the stock in a transaction on Thursday, March 23rd. The stock was bought at an average cost of $0.98 per share, for a total transaction of $49,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 12.40% of the stock is owned by company insiders.
A number of large investors have recently made changes to their positions in SNMX. Prescott Group Capital Management L.L.C. increased its stake in shares of Senomyx by 34.1% in the third quarter. Prescott Group Capital Management L.L.C. now owns 182,300 shares of the specialty chemicals company’s stock valued at $777,000 after buying an additional 46,400 shares during the period. Geode Capital Management LLC increased its stake in shares of Senomyx by 3.9% in the first quarter. Geode Capital Management LLC now owns 271,144 shares of the specialty chemicals company’s stock valued at $268,000 after buying an additional 10,081 shares during the period. Algert Global LLC increased its stake in shares of Senomyx by 19.4% in the first quarter. Algert Global LLC now owns 313,788 shares of the specialty chemicals company’s stock valued at $311,000 after buying an additional 50,881 shares during the period. Cowen Prime Services LLC increased its stake in shares of Senomyx by 0.8% in the first quarter. Cowen Prime Services LLC now owns 345,351 shares of the specialty chemicals company’s stock valued at $342,000 after buying an additional 2,700 shares during the period. Finally, Lagoda Investment Management L.P. purchased a new stake in shares of Senomyx during the third quarter valued at $20,660,000. Institutional investors own 42.38% of the company’s stock.

Gebruikersavatar
Pantanirulez
Forum gebruiker
Forum gebruiker
Berichten: 147
Lid geworden op: 17 Aug 2015 15:32
waarderingen: 55
Contact:

Re: Senomyx

Berichtdoor Pantanirulez » 24 Mei 2017 14:17

Bron:https://tuckermantimes.com/
Senomyx Inc (SNMX) Seeing Increased Volatility in Session

May 22, 2017 William Abels
Shares of Senomyx Inc (SNMX) are moving on volatility today -2.39% or $-0.021 from the open. The NASDAQ listed company saw a recent bid of $0.859 and 407086 shares have traded hands in the session.

Deep diving into the technical levels for Senomyx Inc (SNMX), we note that the equity currently has a 14-day Commodity Channel Index (CCI) of -88.47. Active investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the flip side, a reading below -100 may signal a downtrend reflecting weak price action. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal.

Senomyx Inc’s Williams Percent Range or 14 day Williams %R currently sits at -74.21. The Williams %R oscillates in a range from 0 to -100. A reading between 0 and -20 would point to an overbought situation. A reading from -80 to -100 would signal an oversold situation. The Williams %R was developed by Larry Williams. This is a momentum indicator that is the inverse of the Fast Stochastic Oscillator.

Currently, the 14-day ADX for Senomyx Inc (SNMX) is sitting at 12.60. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would support a strong trend. A value of 50-75 would identify a very strong trend, and a value of 75-100 would lead to an extremely strong trend. ADX is used to gauge trend strength but not trend direction. Traders often add the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to identify the direction of a trend.

The RSI, or Relative Strength Index, is a widely used technical momentum indicator that compares price movement over time. The RSI was created by J. Welles Wilder who was striving to measure whether or not a stock was overbought or oversold. The RSI may be useful for spotting abnormal price activity and volatility. The RSI oscillates on a scale from 0 to 100. The normal reading of a stock will fall in the range of 30 to 70. A reading over 70 would indicate that the stock is overbought, and possibly overvalued. A reading under 30 may indicate that the stock is oversold, and possibly undervalued. After a recent check, the 14-day RSIfor Senomyx Inc (SNMX) is currently at 43.53, the 7-day stands at 38.66, and the 3-day is sitting at 18.27.

Gebruikersavatar
Pantanirulez
Forum gebruiker
Forum gebruiker
Berichten: 147
Lid geworden op: 17 Aug 2015 15:32
waarderingen: 55
Contact:

Re: Senomyx

Berichtdoor Pantanirulez » 25 Mei 2017 10:25

Bron:https://transcriptdaily.com

Critical News Coverage Somewhat Likely to Affect Senomyx (SNMX) Stock Price
Posted by Joseph Casey on May 25th, 2017 // No Comments
Senomyx logoMedia stories about Senomyx (NASDAQ:SNMX) have been trending negative recently, Alpha One reports. The research group, a unit of Accern, identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real-time. Alpha One ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Senomyx earned a media sentiment score of -0.29 on Alpha One’s scale. Alpha One also assigned news headlines about the specialty chemicals company an impact score of 50 out of 100, indicating that recent media coverage is somewhat likely to have an impact on the stock’s share price in the near future.
Senomyx (NASDAQ:SNMX) opened at 0.86 on Thursday. The company has a 50-day moving average of $0.90 and a 200-day moving average of $1.03. The company’s market cap is $40.86 million. Senomyx has a 52 week low of $0.78 and a 52 week high of $4.85.

Senomyx (NASDAQ:SNMX) last issued its quarterly earnings data on Friday, April 28th. The specialty chemicals company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01. Senomyx had a negative return on equity of 54.22% and a negative net margin of 39.68%. The company had revenue of $4.47 million for the quarter, compared to the consensus estimate of $4.22 million. During the same quarter last year, the company earned ($0.05) earnings per share. The firm’s revenue for the quarter was down 28.5% compared to the same quarter last year. On average, equities analysts expect that Senomyx will post ($0.27) EPS for the current year.
SNMX has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Senomyx from a “hold” rating to a “sell” rating in a research note on Saturday, April 29th. Roth Capital set a $2.00 price target on shares of Senomyx and gave the stock a “hold” rating in a research note on Tuesday, May 2nd.
In related news, CEO John Poyhonen acquired 50,000 shares of the company’s stock in a transaction that occurred on Thursday, March 23rd. The shares were bought at an average price of $0.98 per share, with a total value of $49,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 12.40% of the stock is owned by company insiders.

Stefan
Forum actieveling
Forum actieveling
Berichten: 479
Lid geworden op: 18 Dec 2012 18:52
waarderingen: 58
Contact:

Re: Senomyx

Berichtdoor Stefan » 19 Dec 2017 19:48

Senomyx Expands Cool Program Collaboration with Firmenich
Nov 14, 2017, 05:00 ET

SAN DIEGO, Nov. 14, 2017 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX),a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners, and Firmenich, the world's largest privately-owned company in the fragrance and flavor business, announced today the expansion of their Cool Program collaborative agreement.

With this amendment to our Cool Collaboration Agreement, Firmenich continues its long-standing tradition of investing in innovation. Under terms of the amended agreement, Firmenich will be granted an exclusive license to CoolmyxTM CL19 and related cooling ingredients in all product categories. This amendment also includes a license expansion for product categories covering applications in the flavor, oral care and consumer product markets.

"During the second quarter, Senomyx engaged an advisor to pursue strategic options related to certain flavor ingredient assets," stated John Poyhonen, President and Chief Executive Officer of Senomyx. "We have been gratified by the significant third-party interest in this family of cooling ingredients, and we believe that Firmenich's exclusive license of Coolmyx CL19 is an outstanding opportunity for both companies. Signing this amended agreement is consistent with our goal of securing non-dilutive funding to support our corporate priorities."

Under the terms of the amended agreement, Senomyx will receive an upfront payment of $10 million for the exclusive license and pre-payment of Cool Program royalty obligations covering the period from 2018 through 2020. Under the terms of the amended agreement, Firmenich's royalty payment obligations will resume in 2021 and will continue through the length of the agreement.


About Senomyx, Inc.

Senomyx discovers novel flavor ingredients and natural high intensity sweeteners that allow food and beverage companies to create better-for-you products. Under its direct sales program, Senomyx sells its Complimyx® brand flavor ingredients, Sweetmyx®, Savorymyx®, and Bittermyx®, to flavor companies for use in a wide variety of foods and beverages. In addition, Senomyx has partnerships with leading global food, beverage, and ingredient supply companies, which are currently marketing products that contain Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com.

About Firmenich

Firmenich is the world's largest privately-owned company in the fragrance and flavor business. Founded in Geneva, Switzerland, in 1895, it has created many of the world's best-known perfumes and flavors that billions of consumers enjoy each day. Its passion for smell and taste is at the heart of its success. It is renowned for its world-class research and creativity, as well as its thought leadership in sustainability and exceptional understanding of consumer trends. Each year, it invests 10% of its turnover in R&D, reflecting its continuous desire to understand, share and sublimate the best that nature has to offer. Firmenich had an annual turnover of 3.34 billion Swiss Francs at the end of June 2017.


https://www.prnewswire.com/news-release ... 55176.html
Biolase ($1.91)
Senomyx ($1.21)
Thrombogenics (€3,32)

Stefan
Forum actieveling
Forum actieveling
Berichten: 479
Lid geworden op: 18 Dec 2012 18:52
waarderingen: 58
Contact:

Re: Senomyx

Berichtdoor Stefan » 20 Dec 2017 09:31

En nog even een woordje uitleg over Siratose, waar de focus nu volledig naar gericht is:

What is siratose and what is a common or usual name?

Senomyx is introducing our novel, high intensity sweetener under the common or usual name of “siratose.” Siratose is a minor component from monk fruit. This is not a brand name but the name you will see on the ingredient list next to the nutrition facts information area on a packaged food or beverage product.

Examples of common or usual names include sucralose, aspartame and rebaudioside A or steviol glycosides (the latter two are sweeteners that come from the stevia plant).

The name siratose comes in part from the word “siraitia” in Siraitia grosvenorii, which is the Latin, or species, name of the monk fruit plant, also known as luo han guo. The suffix “ose” is used to help identify it as a sweetener ingredient. Per general labeling guidance from the FDA (U.S. Food and Drug Administration), common or usual names must be descriptive of the ingredient, its function, or the chemical name of the active compound.



http://www.senomyx.com/faq-items/what-i ... sual-name/
Biolase ($1.91)
Senomyx ($1.21)
Thrombogenics (€3,32)